BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12651874)

  • 1. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes.
    Dai Z; Zhu WG; Morrison CD; Brena RM; Smiraglia DJ; Raval A; Wu YZ; Rush LJ; Ross P; Molina JR; Otterson GA; Plass C
    Hum Mol Genet; 2003 Apr; 12(7):791-801. PubMed ID: 12651874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas.
    Imoto I; Yang ZQ; Pimkhaokham A; Tsuda H; Shimada Y; Imamura M; Ohki M; Inazawa J
    Cancer Res; 2001 Sep; 61(18):6629-34. PubMed ID: 11559525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy.
    Imoto I; Tsuda H; Hirasawa A; Miura M; Sakamoto M; Hirohashi S; Inazawa J
    Cancer Res; 2002 Sep; 62(17):4860-6. PubMed ID: 12208731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.
    Lin L; Prescott MS; Zhu Z; Singh P; Chun SY; Kuick RD; Hanash SM; Orringer MB; Glover TW; Beer DG
    Cancer Res; 2000 Dec; 60(24):7021-7. PubMed ID: 11156406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.
    Yokoi S; Yasui K; Iizasa T; Imoto I; Fujisawa T; Inazawa J
    Clin Cancer Res; 2003 Oct; 9(13):4705-13. PubMed ID: 14581340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurring Amplification at 11q22.1-q22.2 Locus Plays an Important Role in Lymph Node Metastasis and Radioresistance in OSCC.
    Bhosale PG; Pandey M; Cristea S; Shah M; Patil A; Beerenwinkel N; Schäffer AA; Mahimkar MB
    Sci Rep; 2017 Nov; 7(1):16051. PubMed ID: 29167558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
    Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
    Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
    Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
    J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chromosome 3q26 OncCassette: A multigenic driver of human cancer.
    Fields AP; Justilien V; Murray NR
    Adv Biol Regul; 2016 Jan; 60():47-63. PubMed ID: 26754874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas.
    Balsara BR; Sonoda G; du Manoir S; Siegfried JM; Gabrielson E; Testa JR
    Cancer Res; 1997 Jun; 57(11):2116-20. PubMed ID: 9187106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer.
    Linxweiler M; Linxweiler J; Barth M; Benedix J; Jung V; Kim YJ; Bohle RM; Zimmermann R; Greiner M
    Am J Pathol; 2012 Feb; 180(2):473-83. PubMed ID: 22197383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene amplification of the transcription factor DP1 and CTNND1 in human lung cancer.
    Castillo SD; Angulo B; Suarez-Gauthier A; Melchor L; Medina PP; Sanchez-Verde L; Torres-Lanzas J; Pita G; Benitez J; Sanchez-Cespedes M
    J Pathol; 2010 Sep; 222(1):89-98. PubMed ID: 20556744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA.
    Costello JF; Plass C; Arap W; Chapman VM; Held WA; Berger MS; Su Huang HJ; Cavenee WK
    Cancer Res; 1997 Apr; 57(7):1250-4. PubMed ID: 9102208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
    Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
    Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA copy number gains in head and neck squamous cell carcinoma.
    Lin M; Smith LT; Smiraglia DJ; Kazhiyur-Mannar R; Lang JC; Schuller DE; Kornacker K; Wenger R; Plass C
    Oncogene; 2006 Mar; 25(9):1424-33. PubMed ID: 16247453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer.
    Medina PP; Castillo SD; Blanco S; Sanz-Garcia M; Largo C; Alvarez S; Yokota J; Gonzalez-Neira A; Benitez J; Clevers HC; Cigudosa JC; Lazo PA; Sanchez-Cespedes M
    Hum Mol Genet; 2009 Apr; 18(7):1343-52. PubMed ID: 19153074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allelic losses on chromosomes 1p, 3p, 11p, 11q in non small cell lung cancers].
    Cheng JQ; Crépin M; Hamelin R
    C R Acad Sci III; 1990; 311(5):175-9. PubMed ID: 2169974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer.
    Starczynowski DT; Lockwood WW; Deléhouzée S; Chari R; Wegrzyn J; Fuller M; Tsao MS; Lam S; Gazdar AF; Lam WL; Karsan A
    J Clin Invest; 2011 Oct; 121(10):4095-105. PubMed ID: 21911935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.
    Cheng L; Zhou Z; Flesken-Nikitin A; Toshkov IA; Wang W; Camps J; Ried T; Nikitin AY
    Oncogene; 2010 Oct; 29(42):5700-11. PubMed ID: 20676140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.